Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Université Laval

$180,000.00

Early Bone Fragility as a Marker of Cardiovascular Risk in the Bone-Vascular Axis

EF 2025-26

Résumé
The main idea of this project is that early loss of bone strength may be linked to a higher risk of heart and blood vessel problems in the general population, and that this risk may be even greater in people with chronic kidney disease (CKD). We also believe that changes in bone health occurring before osteoporosis is diagnosed may already be associated with cardiovascular risk, and that treatments commonly used to protect bone (called antiresorptive drugs) could potentially help reduce this risk if used earlier. To study this, we will first analyze data from the CARTaGENE cohort, which includes about 20,000 adults from Quebec. We aim to better understand how bone mineral density and fracture risk are related to the future risk of cardiovascular disease and death in the general population and people with early impaired kidney function. In addition, we will use data from Quebec's public health insurance system to study these relationships in both the general population and in people with more advanced CKD or dialysis. We will then examine whether people who receive antiresorptive treatments (widely given to patients with osteoporosis) have a lower risk of cardiovascular events. Throughout the project, we will pay special attention to possible differences between women and men. We expect to find that early signs of increased bone fragility are associated with a higher risk of cardiovascular complications, particularly among individuals with CKD. Ultimately, this research could help identify new ways to reduce cardiovascular disease by improving bone health, especially in people at high risk.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
565521
Name
Mac-Way Fabrice
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Projecttitle
Early Bone Fragility as a Marker of Cardiovascular Risk in the Bone-Vascular Axis
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bone Fragility; Bone-Vascular Axis; Cardiovascular Disease; Chronic Kidney Disease
Abstract
The main idea of this project is that early loss of bone strength may be linked to a higher risk of heart and blood vessel problems in the general population, and that this risk may be even greater in people with chronic kidney disease (CKD). We also believe that changes in bone health occurring before osteoporosis is diagnosed may already be associated with cardiovascular risk, and that treatments commonly used to protect bone (called antiresorptive drugs) could potentially help reduce this risk if used earlier. To study this, we will first analyze data from the CARTaGENE cohort, which includes about 20,000 adults from Quebec. We aim to better understand how bone mineral density and fracture risk are related to the future risk of cardiovascular disease and death in the general population and people with early impaired kidney function. In addition, we will use data from Quebec's public health insurance system to study these relationships in both the general population and in people with more advanced CKD or dialysis. We will then examine whether people who receive antiresorptive treatments (widely given to patients with osteoporosis) have a lower risk of cardiovascular events. Throughout the project, we will pay special attention to possible differences between women and men. We expect to find that early signs of increased bone fragility are associated with a higher risk of cardiovascular complications, particularly among individuals with CKD. Ultimately, this research could help identify new ways to reduce cardiovascular disease by improving bone health, especially in people at high risk.
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mac-Way, Fabrice
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $180,000~ $0~